Identification of new antiviral agents against Kaposi’s sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation

Jungang Chen(Winthrop Rockefeller Foundation), Zhiqiang Qin(Winthrop Rockefeller Foundation)

PLoS Pathogens

December 2, 2019

10.1371/journal.ppat.1008156

Cited by 33

Related Papers

Systematic Analysis of a Xenograft Mice Model for KSHV+ Primary Effusion Lymphoma (PEL)

|PLoS ONE|2014|27

Celecoxib Inhibits the Lytic Activation of Kaposi’s Sarcoma-Associated Herpesvirus through Down-Regulation of RTA Expression by Inhibiting the Activation of p38 MAPK

|Viruses|2015|20